The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Validating survivin as a cancer therapeutic target
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Self-citation(2001) · PubMed · Cited by 2,381
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Self-citationMechanisms of Caspase Activation and Inhibition during Apoptosis
Shi, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00482-3 · Cited by 1,833
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,244
Meier, P., Finch, A., & Evan, G. (2000) · Nature · doi:10.1038/35037734 · Cited by 1,039
Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., & Ashwell, J. D. (2000) · Science · doi:10.1126/science.288.5467.874 · Cited by 988
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Zong, W.-X., Lindsten, T., Ross, A. J., MacGregor, G. R., & Thompson, C. B. (2001) · Genes & Development · doi:10.1101/gad.897601 · Cited by 808
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki, H., Altieri, D. C., Lu, C., Toyoda, M., Tenjo, T., & Tanigawa, N. (1998) · PubMed · Cited by 706
Self-citationStructural basis for phosphoserine-proline recognition by group IV WW domains.
Verdecia, M. A., Bowman, M. E., Lu, K. P., Hunter, T. R., & Noel, J. P. (2000) · Nature Structural Biology · doi:10.1038/77929 · Cited by 704
From bench to clinic with apoptosis-based therapeutic agents
Nicholson, D. W. (2000) · Nature · doi:10.1038/35037747 · Cited by 687
An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7
Shin, S., Sung, B.-J., Cho, Y.-S., Kim, H.-J., Ha, N.-C., Hwang, J.-I., Chung, C.-W., Jung, Y.-K., & Oh, B.-H. (2001) · Biochemistry · doi:10.1021/bi001603q · Cited by 674
Suzuki, Y., Nakabayashi, Y., & Takahashi, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161506698 · Cited by 654
Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway
Papapetropoulos, A., Fulton, D., Mahboubi, K., Kalb, R. G., O'Connor, D. S., Li, F., Altieri, D. C., & Sessa, W. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9102 · Cited by 641
Self-citationRegulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Self-citationPleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
Self-citationExpression of survivin and its relationship to loss of apoptosis in breast carcinomas
田中, 慶. (2000) · Medical Entomology and Zoology · doi:10.11501/3179364 · Cited by 559
Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205353 · Cited by 530
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
Chromosomal passengers and the (aurora) ABCs of mitosis
Adams, R. R., Carmena, M., & Earnshaw, W. C. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01880-8 · Cited by 525
Adida, C., Crotty, P., McGrath, J., Berrebi, D., Diebold, J., & Altieri, D. C. (1998) · Europe PMC (PubMed Central) · Cited by 504
Self-citationOlie, R. A., Simões‐Wüst, A. P., Baumann, B., Leech, S. H., Fabbro, D., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · PubMed · Cited by 489
Monzó, M., Rosell, R., Felip, E., Astudillo, J., Sánchez, J. J., Maestre, J., Martín, C., Font, A., Barnadas, A., & Abad, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2100 · Cited by 487
Lu, C., Altieri, D. C., & Tanigawa, N. (1998) · PubMed · Cited by 459
Self-citationLivin, a Novel Inhibitor of Apoptosis Protein Family Member
Kasof, G. M., & Gomes, B. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003670200 · Cited by 454
Zhang, T., Otevrel, T., Gao, Z., Gao, Z., Ehrlich, S. M., Fields, J. Z., & Boman, B. M. (2001) · PubMed · Cited by 441
Aoki, Y., Feldman, G. M., & Tosato, G. (2003) · Blood · doi:10.1182/blood-2002-07-2130 · Cited by 438
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
Characterization of XIAP-Deficient Mice
Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3604-3608.2001 · Cited by 422
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., & Altieri, D. C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70294-4 · Cited by 415
Self-citationInduction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting
Ambrosini, G., Adida, C., Sirugo, G., & Altieri, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11177 · Cited by 406
Self-citationIslam, A., Kageyama, H., Takada, N., Kawamato, T., Takayasu, H., Isogai, E., Ohira, M., Hashizume, K., Kobayashi, H., Kaneko, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203358 · Cited by 386
Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma
Grossman, D., McNiff, J. M., Li, F., & Altieri, D. C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00776.x · Cited by 365
Self-citationPrognostic significance of survivin expression in diffuse large B-cell lymphomas.
Adida, C., Haïoun, C., Gaulard, P., Lepage, É., Morel, P., Brière, J., Dombret, H., Reyes, F., Diebold, J., Gisselbrecht, C., et al. (2000) · PubMed · doi:10.1182/blood.v96.5.1921 · Cited by 359
Self-citationHuang, H.-K., Joazeiro, C. A. P., Bonfoco, E., Kamada, S., Leverson, J. D., & Hunter, T. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61427-4 · Cited by 356
Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T. J., & Hung, M.-C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80157-4 · Cited by 353
Bidirectional Gene Organization
Adachi, N., & Lieber, M. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00758-4 · Cited by 346
Kato, J., Kuwabara, Y., Mitani, M., Shinoda, N., Sato, A., Toyama, T., Mitsui, A., Nishiwaki, T., Moriyama, S., Kudo, J., et al. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010320)95:2<92::aid-ijc1016>3.0.co;2-9 · Cited by 345
Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells
O'Connor, D. S., Schechner, J. S., Adida, C., Mesri, M., Rothermel, A. L., Li, F., Nath, A. K., Pober, J. S., & Altieri, D. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64742-6 · Cited by 341
Self-citationStructure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.
Noel, J. P., Verdecia, M. A., Huang, H.-K., Sonnenburg, E. D., Kaiser, D. A., & Hunter, T. R. (2000) · Nature Structural Biology · doi:10.1038/76838 · Cited by 337
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Self-citationTran, J., Rak, J., Sheehan, C., Saibil, S. D., LaCasse, E., Korneluk, R. G., & Kerbel, R. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1589 · Cited by 333
Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma
Sarela, A. I. (2000) · Gut · doi:10.1136/gut.46.5.645 · Cited by 323
Bolton, M. A., Lan, W., Powers, S. E., McCleland, M. L., Kuang, J., & Stukenberg, P. T. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0092 · Cited by 321
A p34cdc2 survival checkpoint in cancer
O'Connor, D. S., Wall, N. R., Porter, A. C. G., & Altieri, D. C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00084-3 · Cited by 315
Self-citationFortugno, P., Wall, N. R., Giodini, A., O'Connor, D. S., Plescia, J., Padgett, K. M., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.575 · Cited by 307
Self-citationTumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer
Swana, H. S., Grossman, D., Anthony, J. N., Weiss, R. M., & Altieri, D. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410614 · Cited by 301
Self-citationTranscriptional analysis of human survivin gene expression
Li, F., & Altieri, D. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440305 · Cited by 286
Self-citationInhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Self-citationQuantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas
Chakravarti, A., Noll, E., Black, P. M., Finkelstein, D., Finkelstein, D. M., Dyson, N. J., & Loeffler, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1063 · Cited by 278
The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner
Zhao, J., Tenev, T., Martins, L. M., Downward, J., & Lemoine, N. R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.23.4363 · Cited by 277
Zaffaroni, N., Pennati, M., Colella, G., Perego, P., Supino, R., Gatti, L., Pilotti, S., Zunino, F., & Daidone, M. G. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8518-3 · Cited by 275
Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity
Tao, W., Zhang, S., Turenchalk, G. S., Stewart, R. A., St John, M. A. R., Chen, W., & Xu, T. (1999) · Nature Genetics · doi:10.1038/5960 · Cited by 263
Andersen, M. H., Pedersen, L. Ø., Becker, J. C., & Straten, P. T. (2001) · PubMed · Cited by 258
Satoh, K., Kaneko, K., Hirota, M., Masamune, A., Satoh, A., & Shimosegawa, T. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2<271::aid-cncr1319>3.0.co;2-0 · Cited by 256
Regulation of microtubule stability and mitotic progression by survivin.
Giodini, A., Kallio, M. J., Wall, N. R., Gorbsky, G. J., Tognin, S., Marchisio, P. C., Symons, M. H., & Altieri, D. C. (2002) · PubMed · Cited by 256
Self-citationGoyal, L. (2001) · Cell · doi:10.1016/s0092-8674(01)00276-8 · Cited by 252
Speliotes, E. K., Uren, A., Vaux, D., & Horvitz, H. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00023-x · Cited by 244
Kobayashi, K., Hatano, M., Otaki, M., Ogasawara, T., & Tokuhisa, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1457 · Cited by 244
Human Survivin Is a Kinetochore-Associated Passenger Protein
Skoufias, D. A., Mollinari, C., Lacroix, F. B., & Margolis, R. L. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.7.1575 · Cited by 236
Suzuki, A., Ito, T., Kawano, H., Hayashida, M., Hayasaki, Y., Tsutomi, Y., Akahane, K., Nakano, T., Miura, M., & Shiraki, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203429 · Cited by 232
Fraser, A. G., James, C., Evan, G. I., & Hengartner, M. O. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80137-7 · Cited by 222
Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanović, S., Ockert, D., Rammensee, H., & Rieber, E. P. (2000) · PubMed · Cited by 219
Sanna, M. G., Correia, J. D. S., Ducrey, O., Lee, J., Nomoto, K., Schrantz, N., Deveraux, Q. L., & Ulevitch, R. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1754-1766.2002 · Cited by 217
Fukuda, S., & Pelus, L. M. (2001) · Blood · doi:10.1182/blood.v98.7.2091 · Cited by 212
Li, F., & Altieri, D. C. (1999) · PubMed · Cited by 208
Self-citationChen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Cowsert, L. M., Bennett, F., Krajewski, S., Krajewska, M., Welsh, K., et al. (2000) · Neoplasia · doi:10.1038/sj.neo.7900091 · Cited by 207
Grossman, D., Kim, P. J., Blanc-Brude, O. P., Brash, D. E., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13345 · Cited by 206
Self-citationCytokine-regulated expression of survivinin myeloid leukemia
Carter, B. Z., Milella, M., Altieri, D. C., & Andreeff, M. (2001) · Blood · doi:10.1182/blood.v97.9.2784 · Cited by 197
Self-citationRole for yeast inhibitor of apoptosis (IAP)-like proteins in cell division
Uren, A. G., Beilharz, T., O’Connell, M. J., Bugg, S. J., van Driel, R., Vaux, D. L., & Lithgow, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10170 · Cited by 192
An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
Hirohashi, Y., Torigoe, T., Maeda, A., Nabeta, Y., Kamiguchi, K., Sato, T., Yoda, J., Ikeda, H., Hirata, K., Yamanaka, N., et al. (2002) · PubMed · Cited by 187
Mesri, M., Morales-Ruiz, M., Ackermann, E. J., Bennett, C. F., Pober, J. S., Sessa, W. C., & Altieri, D. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64131-4 · Cited by 183
Self-citationExpression and prognostic significance of survivin in de novo acute myeloid leukaemia
Adida, C., Récher, C., Raffoux, E., Daniel, M., Taksin, A.-L., Rousselot, P. H., Sigaux, F., Degos, L., Altieri, D. C., & Dombret, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02328.x · Cited by 182
Self-citationExpression of survivin in normal, hyperplastic, and neoplastic colonic mucosa
Gianani, R., Jarboe, E., Orlicky, D., Frost, M., Bobak, J., Lehner, R., & Shroyer, K. R. (2001) · Human Pathology · doi:10.1053/hupa.2001.21897 · Cited by 181
Effects of Survivin Antagonists on Growth of Established Tumors and B7-1 Immunogene Therapy
Kanwar, J. R., Shen, W.-P., Kanwar, R. K., Berg, R. W., & Krissansen, G. W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1541 · Cited by 172
Conway, E. M., Pollefeyt, S., Cornelissen, J., DeBaere, I., Steiner-Mosonyi, M., Ong, K., Baens, M., Collen, D., & Schuh, A. C. (2000) · Blood · doi:10.1182/blood.v95.4.1435.004k01_1435_1442 · Cited by 171
Transcriptional analysis of human survivin gene expression
LI, F., & ALTIERI, D. C. (1999) · Biochemical Journal · doi:10.1042/bj3440305 · Cited by 171
Self-citationWang, H.-W. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2602 · Cited by 165
Itzhaki, J. E., Gilbert, C., & Porter, A. (1997) · Nature Genetics · doi:10.1038/ng0397-258 · Cited by 163
Complexities in the development of cyclin-dependent kinase inhibitor drugs
Sausville, E. A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02308-0 · Cited by 160
LATS1 tumor suppressor regulates G2/M transition and apoptosis
Hong, X., Qi, H., Li, Y., Pei, J., Barton, J., Blackstad, M., Xu, T., & Tao, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205174 · Cited by 158
Schwartz, G. K., O'Reilly, E. M., Ilson, D. H., Saltz, L. B., Sharma, S., Tong, W. P., Maslak, P. G., Stoltz, M., Eden, L., Perkins, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.080 · Cited by 155
Reffey, S. B., Würthner, J., Parks, W. T., Roberts, A. B., & Duckett, C. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100331200 · Cited by 153
Fukuda, S., Foster, R. G., Porter, S. B., & Pelus, L. M. (2002) · Blood · doi:10.1182/blood.v100.7.2463 · Cited by 136
Activation of Cancer-Specific Gene Expression by the Survivin Promoter
Bao, R., Connolly, D. C., Murphy, M., Green, J., Weinstein, J. K., Pisarcik, D. A., & Hamilton, T. C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.7.522 · Cited by 135
Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein Survivin
Muchmore, S. W., Chen, J., Jakob, C. G., Zakula, D., Matayoshi, E. D., Wu, W., Zhang, H., Li, F., Ng, S., & Altieri, D. C. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00018-6 · Cited by 132
Self-citationZhou, M., Gu, L., Li, F., Zhu, Y., Woods, W. G., & Findley, H. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037192 · Cited by 130
Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis
Silke, J., & Vaux, D. L. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1821 · Cited by 121
Mahboubi, K., Li, F., Plescia, J., Kirkiles-Smith, N. C., Mesri, M., Du, Y., Carroll, J. M., Elias, J. A., Altieri, D. C., & Pober, J. S. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780241 · Cited by 114
Self-citationHattori, M., Sakamoto, H., Satoh, K., & Yamamoto, T. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00499-2 · Cited by 112
Shankar, S. L., Mani, S., O’Guin, K., Kandimalla, E. R., Agrawal, S., & Shafit‐Zagardo, B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00596.x · Cited by 109
Deterin, a New Inhibitor of Apoptosis from Drosophila melanogaster
Jones, G., Jones, D., Zhou, L., Steller, H., & Chu, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000369200 · Cited by 98
Conway, E. M., Pollefeyt, S., Steiner‐Mosonyi, M., Luo, W., Vriese, A. D., Lupu, F., Bono, F., Leducq, N., Dol, F., Schaeffer, P., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34753 · Cited by 97
Kamihira, S., Yamada, Y., Hirakata, Y., Tomonaga, M., Sugahara, K., Hayashi, T., Dateki, N., Harasawa, H., & Nakayama, K. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02902.x · Cited by 96
Survivin--a universal tumor antigen.
Andersen, M. H., & thor, S. P. (2002) · PubMed · doi:10.14670/hh-17.669 · Cited by 96
Badie, C., Itzhaki, J. E., Sullivan, M. J., Carpenter, A. J., & Porter, A. C. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2358-2366.2000 · Cited by 83
Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage
Ongkeko, W. M., Ferguson, D. J. P., Harris, A. L., & Norbury, C. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.8.2897 · Cited by 83
Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi, M., Ueta, T., YAMANE, Y., Hirooka, Y., & Kaibara, N. (2002) · PubMed · Cited by 80
Cell Division Regulation by BIR1, a Member of the Inhibitor of Apoptosis Family in Yeast
Li, F., Flanary, P. L., Altieri, D. C., & Dohlman, H. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6707 · Cited by 80
Self-citationParticipation of Survivin in mitotic and apoptotic activities of normal and tumor‐derived cells*
Jiang, X., Wilford, C. E., Duensing, S., Münger, K., Jones, G., & Jones, D. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1228 · Cited by 69
Kallio, M. J., Nieminen, M., & Eriksson, J. (2001) · The FASEB Journal · doi:10.1096/fj.01-0280fje · Cited by 69
Yamamoto, T., Manome, Y., Nakamura, M., & Tanigawa, N. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00247-2 · Cited by 63
Kuttler, F., Valnet‐Rabier, M., Angonin, R., Ferrand, C., Deconinck, É., Mougin, C., Cahn, J.-Y. Y., & Fest, T. (2002) · Leukemia · doi:10.1038/sj.leu.2402427 · Cited by 45
Survivin: a novel neuroendocrine marker for pheochromocytoma
Koch, C. A., Vortmeyer, A., Diallo, R. I., Poremba, C., Giordano, T. J., Sanders, D. J., Bornstein, S., Chrousos, G., & Pacák, K. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460381 · Cited by 36
Cited by
Targeting IAP proteins for therapeutic intervention in cancer
Fulda, S., & Vucic, D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3627 · Cited by 837
Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease
FADEEL, B., & ORRENIUS, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 698
Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1752 · Cited by 563
Survivin, a cancer target with an emerging role in normal adult tissues
Fukuda, S., & Pelus, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0375 · Cited by 465
Srinivasula, S. M., & Ashwell, J. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.008 · Cited by 450
Metadata
- Authors
- Altieri, D. C.
- Venue
- Nature Reviews Cancer
- Published
- 2003-01
- Volume
- 3
- Issue
- 1
- Pages
- 46-54
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2064580048
- Cited by
- 1,206
- References
- 112
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.